Published in Messenger (Los Angel) on December 01, 2012
Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature (1983) 10.90
Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem (2001) 8.47
VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A (2002) 8.10
Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J Immunol (1988) 3.23
Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med (2000) 2.08
Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer (2002) 1.79
Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates. EMBO J (2004) 1.77
Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood (2000) 1.74
alpha4beta1 integrin regulates lamellipodia protrusion via a focal complex/focal adhesion-independent mechanism. Mol Biol Cell (2002) 1.45
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Cancer Res (2005) 1.38
Inositol pentakisphosphate promotes apoptosis through the PI 3-K/Akt pathway. Oncogene (2004) 1.28
SHIP1 and Lyn Kinase Negatively Regulate Integrin alpha IIb beta 3 signaling in platelets. J Biol Chem (2004) 1.25
Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr (1998) 1.19
Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. Blood (2003) 1.08
The inhibition of phosphoinositide synthesis and muscarinic-receptor-mediated phospholipase C activity by Li+ as secondary, selective, consequences of inositol depletion in 1321N1 cells. Biochem J (1994) 1.05
Do mammals make all their own inositol hexakisphosphate? Biochem J (2008) 1.03
The molecular physiology and pathology of fibrin structure/function. Blood Rev (2005) 1.00
Fibrinogen mediates bladder cancer cell migration in an ICAM-1-dependent pathway. Thromb Haemost (2003) 1.00
Absorption and excretion of orally administered inositol hexaphosphate (IP(6) or phytate) in humans. Biofactors (2001) 0.99
Effect of anti-cancer drugs on the binding of 125I-Fibrinogen to two leukaemia cell lines in vitro. J Int Med Res (2004) 0.93
scyllo-inositol pentakisphosphate as an analogue of myo-inositol 1,3,4,5,6-pentakisphosphate: chemical synthesis, physicochemistry and biological applications. Chembiochem (2006) 0.93
Phytic acid (IP6), novel broad spectrum anti-neoplastic agent: a systematic review. Complement Ther Med (2002) 0.93
Biphenyl 2,3',4,5',6-pentakisphosphate, a novel inositol polyphosphate surrogate, modulates Ca2+ responses in rat hepatocytes. FASEB J (2007) 0.93
The regulation of membrane to cytosol partitioning of signalling proteins by phosphoinositides and their soluble headgroups. Biochem Soc Trans (2005) 0.92
Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells. Cancer Res (2000) 0.92
Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury. Biochem Pharmacol (2002) 0.91
A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1. J Biol Chem (1997) 0.91
Heparin-binding domain of fibrin mediates its binding to endothelial cells. Arterioscler Thromb Vasc Biol (1996) 0.91
A alpha and B beta chains of fibrinogen stimulate proliferation of human fibroblasts. J Cell Sci (1993) 0.89
ICAM-1 and p38 MAPK mediate fibrinogen-induced migration of human vascular smooth muscle cells. Eur J Pharmacol (2007) 0.87
Benzene polyphosphates as tools for cell signalling: inhibition of inositol 1,4,5-trisphosphate 5-phosphatase and interaction with the PH domain of protein kinase Balpha. Chembiochem (2008) 0.86
G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6). Anticancer Res (2001) 0.85
2-O-(2-Aminoethyl)-myo-inositol 1,4,5-trisphosphate as a novel ligand for conjugation: physicochemical properties and synthesis of a new Ins(1,4,5)P(3) affinity matrix. Biochem Biophys Res Commun (2004) 0.80
Inositolhexakisphosphate (InsP6): an antagonist of fibroblast growth factor receptor binding and activity. In Vitro Cell Dev Biol Anim (1994) 0.80
Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis. Nutr Cancer (1997) 0.80
Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy. Med Hypotheses (2006) 0.78